Discover 1,271 paid clinical trials in Surprise, Arizona. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,271
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: Phoenix AZ, Scottsdale AZ, Los Angeles CA,
Sponsor: Dianthus Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT06858579
Phase3, Recruiting
Lysosomal Acid Lipase (LAL) Deficiency Registry
for
Lysosomal Acid Lipase Deficiency,
Location: Phoenix AZ, Stanford CA, Snyder TX, Houston TX,
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All
Age: 0+
Code: NCT01633489
Recruiting
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
for
Osteoarthritis, Overweight or Obesity
Location: Phoenix AZ, Mesa AZ, Tucson AZ, Spring Valley CA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07353931
Phase3, Recruiting
A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
for
Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia
Location: Scottsdale AZ, Chandler AZ, Henderson NV, Santa Ana CA,
Sponsor: Centessa Pharmaceuticals (UK) Limited
Sex: All
Age: 18 - 65
Code: NCT06752668
Phase2, Recruiting
Effect of a Fermented Dairy Protein With Prebiotic Fiber on GI Complaints
for
Digestive Health, Quality of Life
Location: Phoenix AZ
Sponsor: Arizona State University
Sex: All
Age: 18 - 50
Code: NCT06946017
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin
for
Growth Hormone Deficiency
Location: Phoenix AZ, Las Vegas NV, Orange CA, El Paso TX,
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
for
Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia
Location: Phoenix AZ, Los Angeles CA, Colorado Springs CO,
Sponsor: Alkermes, Inc.
Sex: All
Age: 18 - 70
Code: NCT06767683
Phase2, Phase3, Recruiting
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations